Back to News
2019 IQ Recognition Award Recipients Announced
October 7, 2019
IQ's initiatives are undertaken by teams of dedicated and passionate members. Each year, the IQ Consortium recognizes participants who have made significant contributions toward these initiatives. The Leadership Group and Working Group participants listed below are recipients of the 2019 IQ Recognition Award for outstanding contributions, engagement and leadership.
| IQ Outgoing Leadership Group Chair Award Recipients | ||
|---|---|---|
|
(by Leadership Group) |
||
| Active Pharmaceutical Ingredient | 3Rs Translational and Predictive Sciences | |
| Timothy Curran, PhD Vertex Pharmaceuticals Chair, 2019 Vice Chair, 2017-2018 |
Szczepan Baran, VMD, MS Novartis Pharmaceuticals Chair, 2019 Vice Chair, 2018 |
|
| Analytical | DruSafe | |
| Mark D. Argentine, PhD Eli Lilly and Company Chair, 2019 Vice Chair, 2018 |
Donna M. Dambach, VMD, PhD, DACVP, FATS Past Chair, 2019 Chair, 2018 Vice Chair, 2017 Vice Chair Elect, 2016 |
|
| Drug Product | ||
| Ahmad Almaya, PhD Eli Lilly and Company Chair, 2019 Vice Chair, 2018 |
||
| IQ Recognition Award Recipients | ||
|
(by Leadership Group) |
||
| 3Rs Translational and Predictive Sciences | Translational and ADME Sciences | |
| Holly Burr, Bristol-Myers Squibb | Nancy Agrawal, Merck & Co., Inc. | |
| Sean Maguire, GlaxoSmithKline | Yuan Chen, Genentech | |
| Jerry Poling, Eli Lilly and Company | Arian Emami Riedmaier, AbbVie, Inc. | |
| Smita Salian-Mehta, AbbVie, Inc. | Mary Spilker, Pfizer, Inc. | |
| Andy Zuvich, Incyte | ||
| Biologics CMC | Drug Product | |
| Mario Hubert, Celgene | Beth Galella, Bristol-Myers Squibb | |
| Linda Narhi, Amgen, Inc. | Yuet Mei Khong, AbbVie, Inc. | |
| Paul Wu, Bayer | David Tan, AbbVie, Inc. | |
| DruSafe | Clinical Pharmacology | |
| Joel Bercu, Gilead | David Boulton, AstraZeneca | |
| Lorrene Buckley, Eli Lilly and Company | Amy Cheung, formerly with AstraZeneca | |
| Jamie DaSilva, Pfizer, Inc. | Jack Cook, Pfizer, Inc. | |
| Eric Harstad, Theravance | Richard Czerniak, Takeda | |
| Bart Jessen, Pfizer, Inc. | Leslie Dickmann, formerly with Genentech | |
| Susan Laffan, GlaxoSmithKline | Richard Graham, Theravance | |
| Michael Leach, Pfizer, Inc. | Sebastian Haertter, Boehringer Ingelheim | |
| Liz Mortimer-Cassen, AstraZeneca | Angela James, Astellas Pharma | |
| John Nicolette, AbbVie, Inc. | Makoto Kayama, Astellas Pharma | |
| Lindsay Tomlinson, Pfizer, Inc. | Prajakti Kothare, Merck & Co., Inc. | |
| Yvonne VanGessel, Eisai | Mindy Magee, GlaxoSmithKline | |
| Cynthia (CJ) Musante, Pfizer, Inc. | ||
| Quality | Analytical | |
| Jeffrey Beebie, Pfizer, Inc. | Andreas Abend, Merck & Co., Inc. | |
| Tom Cullen, AbbVie, Inc. | Mark Argentine, Eli Lilly and Company | |
| Lorrie Day, GlaxoSmithKline | Tom Cullen, AbbVie, Inc. | |
| Scott Dunham, Merck & Co., Inc. | Rusty Hertzler, AbbVie, Inc. | |
| Karen Evans, GlaxoSmithKline | Julie Lippke, Pfizer, Inc. | |
| Chris Grosso, Merck & Co., Inc. | Brian Regler, Merck & Co., Inc. | |
| Julie Lippke, Pfizer, Inc. | ||
| Ganapathy Mohan, Merck & Co., Inc. | ||
| Christopher Turner, Celgene | ||
| Active Pharmaceutical Ingredient | IQ DILI Affiliate | |
| Kevin Seibert, Eli Lilly and Company | Arie Regev, Eli Lilly and Company | |
| Sharin Roth, Otsuka | ||
| Philip Sherratt, Celgene | ||